Treatments for Leber Congenital Amaurosis and Retinitis Pigmentosa

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

QLT Obtains Orphan Drug Status for Drug to Treat Leber Congenital Amaurosis and Retinitis Pigmentosa

Posted By Dr. Ari Weitzner On December 9, 2010 @ 8:42 am In Retina | Comments Disabled

Biotech company, QLT Inc., announced earlier this week that the FDA has granted orphan drug designation for QLT091001, its oral synthetic retinoid for the treatment of Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).

Click here ^[1] and here ^[2] to read the relevant press releases.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/004247-qlt-obtains-orphan-drug-status-for-drugs-to-treat-leber-congenital-amaurosis-and-retinitis-pigmentosa/

URLs in this post:

[1] here: http://phoenix.corporate-ir.net/phoenix.zhtml?c=67181&p=irol-newsArticle&ID=1505528&highlight=

[2] here: http://phoenix.corporate-ir.net/phoenix.zhtml?c=67181&p=irol-newsArticle&ID=1505523&highlight=

Click here to print.